Track the 클래시스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 클래시스 has recorded 13 insider filings. The latest transaction was disclosed on 16 July 2026 (Purchase). Among the most active insiders: BCPECenturInvestments,LP. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
13 of 13 declarations
클래시스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for wellness and health.